These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 18528281)
1. Ki-67 immunoreactivity in type II malformations of cortical development. Prayson RA Appl Immunohistochem Mol Morphol; 2008 Jul; 16(4):357-61. PubMed ID: 18528281 [TBL] [Abstract][Full Text] [Related]
2. Differential expression patterns of chloride transporters, Na+-K+-2Cl--cotransporter and K+-Cl--cotransporter, in epilepsy-associated malformations of cortical development. Aronica E; Boer K; Redeker S; Spliet WG; van Rijen PC; Troost D; Gorter JA Neuroscience; 2007 Mar; 145(1):185-96. PubMed ID: 17207578 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of fibroblast growth factor (FGF)-2 in epilepsy-associated malformations of cortical development (MCDs). Sugiura C; Miyata H; Ueda M; Ohama E; Vinters HV; Ohno K Neuropathology; 2008 Aug; 28(4):372-81. PubMed ID: 18179408 [TBL] [Abstract][Full Text] [Related]
4. Increased Ki-67 immunoreactivity in the white matter in hemimegalencephaly. Munakata M; Watanabe M; Otsuki T; Itoh M; Uematsu M; Saito Y; Honda R; Kure S Neurosci Lett; 2013 Aug; 548():244-8. PubMed ID: 23721782 [TBL] [Abstract][Full Text] [Related]
5. Histopathologic findings of malformations of cortical development in an epilepsy surgery cohort. Morris EB; Parisi JE; Buchhalter JR Arch Pathol Lab Med; 2006 Aug; 130(8):1163-8. PubMed ID: 16879017 [TBL] [Abstract][Full Text] [Related]
6. Clinical and histopathological outcomes in patients with SCN1A mutations undergoing surgery for epilepsy. Skjei KL; Church EW; Harding BN; Santi M; Holland-Bouley KD; Clancy RR; Porter BE; Heuer GG; Marsh ED J Neurosurg Pediatr; 2015 Dec; 16(6):668-74. PubMed ID: 26339958 [TBL] [Abstract][Full Text] [Related]
7. Increased expression of matrix metalloproteinase 9 in cortical lesions from patients with focal cortical dysplasia type IIb and tuberous sclerosis complex. Li S; Yu S; Zhang C; Shu H; Liu S; An N; Yang M; Yin Q; Yang H Brain Res; 2012 May; 1453():46-55. PubMed ID: 22459050 [TBL] [Abstract][Full Text] [Related]
8. [Macro- and microscopic systematization of cerebral cortex malformations in children]. Milovanov AP; Milovanova OA Arkh Patol; 2011; 73(5):23-7. PubMed ID: 22288167 [TBL] [Abstract][Full Text] [Related]
9. Focal cortical dysplasia type II (malformations of cortical development) aberrantly expresses apoptotic proteins. Chamberlain WA; Prayson RA Appl Immunohistochem Mol Morphol; 2008 Oct; 16(5):471-6. PubMed ID: 18594472 [TBL] [Abstract][Full Text] [Related]
10. Malformations of cortical development (MCDs) and epilepsy: experience from a tertiary care center in south India. Mathew T; Srikanth SG; Satishchandra P Seizure; 2010 Apr; 19(3):147-52. PubMed ID: 20144553 [TBL] [Abstract][Full Text] [Related]
11. Cortical neuronal densities and lamination in focal cortical dysplasia. Thom M; Martinian L; Sen A; Cross JH; Harding BN; Sisodiya SM Acta Neuropathol; 2005 Oct; 110(4):383-92. PubMed ID: 16151726 [TBL] [Abstract][Full Text] [Related]
12. Doublecortin-like (DCL) expression in focal cortical dysplasia and cortical tubers. Boer K; Lucassen PJ; Spliet WG; Vreugdenhil E; van Rijen PC; Troost D; Jansen FE; Aronica E Epilepsia; 2009 Dec; 50(12):2629-37. PubMed ID: 19583781 [TBL] [Abstract][Full Text] [Related]
13. [Activation of mTOR in maldeveloped balloon cells and dysmorphic neurons of type II focal cortical dysplasia]. Lin K; Lin YX; Kang DZ; Ye ZX; Wang XF Zhonghua Bing Li Xue Za Zhi; 2013 May; 42(5):311-5. PubMed ID: 24004587 [TBL] [Abstract][Full Text] [Related]
14. Expression of the interleukin 6 system in cortical lesions from patients with tuberous sclerosis complex and focal cortical dysplasia type IIb. Shu HF; Zhang CQ; Yin Q; An N; Liu SY; Yang H J Neuropathol Exp Neurol; 2010 Aug; 69(8):838-49. PubMed ID: 20613633 [TBL] [Abstract][Full Text] [Related]
15. Over-expression of P-glycoprotein in malformations of cortical development. Sisodiya SM; Heffernan J; Squier MV Neuroreport; 1999 Nov; 10(16):3437-41. PubMed ID: 10599858 [TBL] [Abstract][Full Text] [Related]
16. [Focal cortical dysplasia with refractory epilepsy: clinicopathologic study of 38 cases]. Piao YS; Chen L; Fu YJ; Wang W; Li YJ; Lu DH Zhonghua Bing Li Xue Za Zhi; 2007 Mar; 36(3):150-4. PubMed ID: 17535679 [TBL] [Abstract][Full Text] [Related]
17. Abnormal maturation of non-dysmorphic neurons in focal cortical dysplasia: immunohistochemical considerations. Hanai S; Saito T; Nakagawa E; Arai A; Otsuki T; Sasaki M; Goto Y; Itoh M Seizure; 2010 Jun; 19(5):274-9. PubMed ID: 20452788 [TBL] [Abstract][Full Text] [Related]
18. Expression of TRPV1 in cortical lesions from patients with tuberous sclerosis complex and focal cortical dysplasia type IIb. Shu HF; Yu SX; Zhang CQ; Liu SY; Wu KF; Zang ZL; Yang H; Zhou SW; Yin Q Brain Dev; 2013 Mar; 35(3):252-60. PubMed ID: 22647236 [TBL] [Abstract][Full Text] [Related]
19. Upregulated expression of voltage-gated sodium channel Nav1.3 in cortical lesions of patients with focal cortical dysplasia type IIb. Yu S; Li S; Shu H; Zhang C; He J; Fan X; Yang H Neuroreport; 2012 May; 23(7):407-11. PubMed ID: 22494998 [TBL] [Abstract][Full Text] [Related]
20. Interobserver and intraobserver reproducibility in focal cortical dysplasia (malformations of cortical development). Chamberlain WA; Cohen ML; Gyure KA; Kleinschmidt-DeMasters BK; Perry A; Powell SZ; Qian J; Staugaitis SM; Prayson RA Epilepsia; 2009 Dec; 50(12):2593-8. PubMed ID: 19817804 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]